Found: 56
Select item for more details and to access through your institution.
CD26 expression on T-anaplastic large cell lymphoma (ALCL) line Karpas 299 is associated with increased expression of versican and MT1-MMP and enhanced adhesion.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Tumor-to-tumor metastasis of diffuse large B cell lymphoma to gastric adenocarcinoma via CXCL12 (SDF-1)/CXCR4 axis: a case report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 583, doi. 10.1111/bjh.14820
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 177, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13014
- By:
- Publication type:
- Article
Long term results of a phase 2 study of vincristine sulfate liposome injection ( Marqibo<sup>®</sup>) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non- Hodgkin lymphomas
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 5, p. 631, doi. 10.1111/bjh.12446
- By:
- Publication type:
- Article
Prevention of acute graft-versus-host disease by humanized anti- CD26 monoclonal antibody.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 2, p. 263, doi. 10.1111/bjh.12378
- By:
- Publication type:
- Article
Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody.
- Published in:
- Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00273-0
- By:
- Publication type:
- Article
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-017-0087-0
- By:
- Publication type:
- Article
Successful Surgical Removal of the Largest Known Spleen.
- Published in:
- Case Reports in Surgery, 2020, p. 1, doi. 10.1155/2020/6790808
- By:
- Publication type:
- Article
CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086671
- By:
- Publication type:
- Article
HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L).
- Published in:
- Oncogene, 2005, v. 24, n. 7, p. 1262, doi. 10.1038/sj.onc.1208261
- By:
- Publication type:
- Article
Novel Antibody Approaches for T-Cell Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, p. S193
- By:
- Publication type:
- Article
Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 8, p. 3918, doi. 10.1002/cam4.2278
- By:
- Publication type:
- Article
DPP8 is a novel therapeutic target for multiple myeloma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54695-w
- By:
- Publication type:
- Article
Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma: The M. D. Anderson Cancer Center experience.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 2091
- By:
- Publication type:
- Article
Thalidomide for patients with recurrent lymphoma.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 6, p. 1186
- By:
- Publication type:
- Article
A Novel Case of Penile Gangrene in a Patient Treated with Ibrutinib for Chronic Lymphocytic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Low Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging?
- Published in:
- Case Reports in Oncological Medicine, 2016, p. 1, doi. 10.1155/2016/8125898
- By:
- Publication type:
- Article
Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission.
- Published in:
- Case Reports in Oncological Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/123756
- By:
- Publication type:
- Article
New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.
- Published in:
- Diagnostic Pathology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1746-1596-9-30
- By:
- Publication type:
- Article
G1/S cell cycle arrest provoked in human T cells by antibody to CD26.
- Published in:
- Immunology, 2002, v. 107, n. 3, p. 325, doi. 10.1046/j.1365-2567.2002.01510.x
- By:
- Publication type:
- Article
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 9, p. 1126, doi. 10.1038/bjc.2017.62
- By:
- Publication type:
- Article
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of Two Commercial ELISAs against an In-House ELISA for Measuring Soluble CD26 in Human Serum.
- Published in:
- Journal of Clinical Laboratory Analysis, 2015, v. 29, n. 2, p. 106, doi. 10.1002/jcla.21736
- By:
- Publication type:
- Article
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma.
- Published in:
- Case Reports in Hematology, 2012, p. 1, doi. 10.1155/2012/954201
- By:
- Publication type:
- Article
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 6, p. 1, doi. 10.1038/s41419-021-03787-5
- By:
- Publication type:
- Article
De novo maintenance therapy with denileukin diftitox (Ontak®) in a patient with peripheral T-cell lymphoma is associated with prolonged remission.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 7, p. 596, doi. 10.1002/ajh.21177
- By:
- Publication type:
- Article
Intravascular Large B-Cell Lymphoma Presenting as Acute Axonal Polyneuropathy: A Case Report and Literature Review.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2020, v. 8, p. 1, doi. 10.1177/2324709620959997
- By:
- Publication type:
- Article
Intravascular Large B-Cell Lymphoma Presenting as Acute Axonal Polyneuropathy: A Case Report and Literature Review.
- Published in:
- Journal of Investigative Medicine High Impact Case Reports, 2020, v. 8, n. 1, p. 1, doi. 10.1177/2324709620959997
- By:
- Publication type:
- Article
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 16, p. 2059, doi. 10.3390/cells12162059
- By:
- Publication type:
- Article
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 7, p. 1100, doi. 10.3390/cells12071100
- By:
- Publication type:
- Article
CD26-mediated co-stimulation in human CD8<sup>+</sup> T cells provokes effector function via pro-inflammatory cytokine production.
- Published in:
- Immunology, 2013, v. 138, n. 2, p. 165, doi. 10.1111/imm.12028
- By:
- Publication type:
- Article
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 4, p. 502, doi. 10.1111/j.1365-2141.2007.06684.x
- By:
- Publication type:
- Article
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 3, p. 439, doi. 10.1111/j.1365-2141.2006.06457.x
- By:
- Publication type:
- Article
T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 6, p. 857, doi. 10.1046/j.1365-2141.2003.04365.x
- By:
- Publication type:
- Article
Comparative Study of Regulatory T Cell Function of Human CD25<sup>+</sup>CD4<sup>+</sup> T Cells from Thymocytes, Cord Blood, and Adult Peripheral Blood.
- Published in:
- Clinical & Developmental Immunology, 2008, p. 1, doi. 10.1155/2008/305859
- By:
- Publication type:
- Article
Combination Therapy for Renal Cell Cancer: What Are Possible Options?
- Published in:
- Oncology, 2011, v. 81, n. 3/4, p. 220, doi. 10.1159/000333470
- By:
- Publication type:
- Article
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 5, p. 721, doi. 10.1080/14397595.2018.1532559
- By:
- Publication type:
- Article
Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-I.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 4, p. 562, doi. 10.3109/14397595.2014.983262
- By:
- Publication type:
- Article
T-cell activation via CD26 and caveolin-1 in rheumatoid synovium.
- Published in:
- Modern Rheumatology, 2006, v. 16, n. 1, p. 3, doi. 10.3109/s10165-005-0452-4
- By:
- Publication type:
- Article
CD26: a key molecule in immune regulation and autoimmune diseases.
- Published in:
- Modern Rheumatology, 2003, v. 13, n. 3, p. 199, doi. 10.3109/s10165-003-0224-y
- By:
- Publication type:
- Article
A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers.
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 1, p. 118
- By:
- Publication type:
- Article
Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.
- Published in:
- PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0218330
- By:
- Publication type:
- Article
A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12150, doi. 10.3390/ijms241512150
- By:
- Publication type:
- Article
ALK1 as a novel therapeutic target for CD30⁺ T-anaplastic large cell lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
ALK1 as a Novel Therapeutic Target for CD30<sup>+</sup>T-Anaplastic Large Cell Lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- Editorial